What Researchers Did
The researchers searched two medical databases for published case series on treatments for livedoid vasculopathy, a painful ulcer-forming condition of the lower legs, and combined what they found.
What They Found
This systematic review of 29 case series covering 339 patients found that many different treatments, including hyperbaric oxygen, were reported to have a favorable outcome, with anticoagulants the most commonly used single therapy at 62 of 63 patients (98%) with a favorable response. Of the 339 patients, 230 (68%) were female and 69 (20%) were male, and sex was not stated for 40. The other treatments listed were antiplatelets, anabolic steroids, thrombolytics, intravenous immunoglobulins, vitamin supplementation and UV light, and combinations of these. Adverse events were seen in 44 patients (13%).
What This Means for Canadian Patients
The abstract lists hyperbaric oxygen as one of several treatments with a favorable outcome in these case series, but it gives no results, pressures or session counts for hyperbaric oxygen on its own. The authors say no established treatment exists for livedoid vasculopathy and that the evidence comes mainly from case reports and case series. Patients with this condition should talk with their physician about the options.
Canadian Relevance
The study or its authors have a Canadian connection.
Study Limitations
The review is based only on case reports and case series, which are low levels of evidence, so it cannot show that any one treatment works better than another, and the authors say randomized clinical trials are still needed.